EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparative in vitro efficacy of aztreonam-avibactam and other alternatives (cefepime-taniborbactam, cefepime-zidebactam, and cefiderocol) against metallo-β-lactamase-producing Enterobacterales isolated in 2024 in France

Cécile Emeraud iD, Marion Dutkiewicz iD, Laurent Dortet iD

Antimicrobial Agents and Chemotherapy · 06.05.2026 · 70 (5)

DOI: 10.1128/aac.00176-26 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 06.05.2026. Verfasst von Cécile Emeraud und 2 weiteren Autor:innen. Beteiligte Einrichtung: Team "Resist" UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Université Paris-Saclay, CEA, LabEx L…. Hauptthemen laut MEDLINE: Cefepime, Cephalosporins, Azabicyclo Compounds, Aztreonam. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pfizer UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We evaluated the in vitro activity of aztreonam-avibactam and other agents against 593 metallo-β-lactamase (MBL)-producing Enterobacterales collected in France in 2024. Aztreonam-avibactam showed the highest activity (98% susceptible), with resistance mainly observed in NDM-5-producing Escherichia coli belonging to ST167, ST405, and ST361. Cefepime-zidebactam also exhibited strong activity (96.6% of susceptibility). Cefepime-taniborbactam and cefiderocol showed reduced overall activity (76.4% and 74.9% susceptibility, respectively), with reduced efficacy mainly observed among NDM-producing isolates. Comparison with 1,465 isolates from 2023 showed no increase in aztreonam-avibactam resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CefepimeCephalosporinsAzabicyclo CompoundsAztreonamAnti-Bacterial Agentsbeta-LactamasesEnterobacteriaceaeCefiderocolMicrobial Sensitivity TestsFranceDrug CombinationsThird Generation CephalosporinsHumansEscherichia coliBorinic AcidsPiperidinesCarboxylic AcidsCyclooctanes

Stichwörter der Autor:innen

MBL-producing EnterobacteralesNDMVIMantimicrobial resistanceaztreonam-avibactamcefiderocolsusceptibility

Substanzen

CefepimeCephalosporinsCefiderocolAzabicyclo CompoundsAztreonamAnti-Bacterial Agentsbeta-Lactamasestaniborbactamcefepime-zidebactamDrug Combinations

Autor:innen und Institutionen

  • Team "Resist" UMR1184 Immunology of Viral, Auto-Immune, Hematological and Bacterial Diseases (IMVA-HB), INSERM, Université Paris-Saclay, CEA, LabEx LERMIT, Faculty of Medicine, Le Kremlin-Bicêtre, France.
  • Bacteriology-Hygiene Unit, Bicêtre Hospital, Assistance Publique-Hôpitaux de Paris (APHP), Le Kremlin-Bicêtre, France.
  • Associated French National Reference Center for Antibiotic Resistance: Carbapenemase-Producing Enterobacteriaceae, Le Kremlin-Bicêtre, France.
  • SEPSIS Comprehensive Center-IHU SEPSIS, Garches, France.

ORCID-Profile: Cécile Emeraud, Marion Dutkiewicz, Laurent Dortet

Förderung

  • Pfizer UK

Zitieren

APA

Emeraud, C., Dutkiewicz, M., & Dortet, L. (2026). Comparative in vitro efficacy of aztreonam-avibactam and other alternatives (cefepime-taniborbactam, cefepime-zidebactam, and cefiderocol) against metallo-β-lactamase-producing Enterobacterales isolated in 2024 in France. Antimicrobial Agents and Chemotherapy, 70(5). https://doi.org/10.1128/aac.00176-26

Vancouver

Emeraud C, Dutkiewicz M, Dortet L. Comparative in vitro efficacy of aztreonam-avibactam and other alternatives (cefepime-taniborbactam, cefepime-zidebactam, and cefiderocol) against metallo-β-lactamase-producing Enterobacterales isolated in 2024 in France. Antimicrobial Agents and Chemotherapy. 2026;70(5). doi:10.1128/aac.00176-26

BibTeX
@article{Emeraud2026,
  author = {Emeraud, Cécile and Dutkiewicz, Marion and Dortet, Laurent},
  title = {Comparative in vitro efficacy of aztreonam-avibactam and other alternatives (cefepime-taniborbactam, cefepime-zidebactam, and cefiderocol) against metallo-β-lactamase-producing Enterobacterales isolated in 2024 in France},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2026},
  volume = {70},
  number = {5},
  doi = {10.1128/aac.00176-26}
}
Kostenlos starten →